Financial Health Check: Examining Seelos Therapeutics Inc (SEEL)’s Key Ratios

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Seelos Therapeutics Inc (NASDAQ: SEEL) closed the day trading at $3.41 up 13.67% from the previous closing price of $3.00. In other words, the price has increased by $13.67 from its previous closing price. On the day, 0.63 million shares were traded. SEEL stock price reached its highest trading level at $3.83 during the session, while it also had its lowest trading level at $2.7701.

Ratios:

For a better understanding of SEEL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.08 and its Current Ratio is at 0.08.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, ROTH Capital on September 27, 2021, Upgraded its rating to Buy and sets its target price to $8 from $2.50 previously.

On July 01, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $8.

On June 01, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.Cantor Fitzgerald initiated its Overweight rating on June 01, 2021, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 30 ’23 when Golembiewski Michael Joseph bought 83,000 shares for $1.21 per share. The transaction valued at 100,222 led to the insider holds 86,450 shares of the business.

Mehra Raj bought 75,757 shares of SEEL for $99,999 on Dec 01 ’23. The insider now owns 185,142 shares after completing the transaction at $1.32 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SEEL now has a Market Capitalization of 1981210 and an Enterprise Value of 11132563. As of this moment, Seelos’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98. Its current Enterprise Value per Revenue stands at 5.528.

Stock Price History:

Over the past 52 weeks, SEEL has reached a high of $848.64, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -23.35%, while the 200-Day Moving Average is calculated to be -94.46%.

Shares Statistics:

Over the past 3-months, SEEL traded about 527.43K shares per day on average, while over the past 10 days, SEEL traded about 2632515 shares per day. Insiders hold about 1.43% of the company’s shares, while institutions hold 2.30% stake in the company. Shares short for SEEL as of 1726185600 were 7305 with a Short Ratio of 0.01, compared to 1723680000 on 5580. Therefore, it implies a Short% of Shares Outstanding of 7305 and a Short% of Float of 1.68.

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.

Revenue Estimates

Based on 1 analysts’ estimates, the company’s revenue will be $28.4M in the next fiscal year. The high estimate is $28.4M and the low estimate is $28.4M.

Most Popular